Page last updated: 2024-10-24

candesartan cilexetil and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous

candesartan cilexetil has been researched along with Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous in 2 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, H1
Furugori, K1
Shibata, D1
Harata, T1
Murata, Y1
Mizutani, S1
Ata, B1
Yakin, K1
Alatas, C1
Urman, B1

Trials

1 trial available for candesartan cilexetil and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous

ArticleYear
Dual renin-angiotensin blockage and total embryo cryopreservation is not a risk-free strategy in patients at high risk for ovarian hyperstimulation syndrome.
    Fertility and sterility, 2008, Volume: 90, Issue:3

    Topics: Adult; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Combined Modality Thera

2008

Other Studies

1 other study available for candesartan cilexetil and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous

ArticleYear
Dual renin-angiotensin blockade therapy in patients at high risk of early ovarian hyperstimulation syndrome receiving IVF and elective embryo cryopreservation: a case series.
    Human reproduction (Oxford, England), 2003, Volume: 18, Issue:6

    Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; B

2003